Switch View
© PR Newswire
03.09.2025
ISIN: CA89788C1041
Trulieve Cannabis Corp
TRUL
LISTED
CSE
Trulieve Wins Seven Brandon Hall Group Awards for Excellence in Employee Development
News Preview
Recognized for innovative learning, development, and talent management programs
TALLAHASSEE, Fla., Sept. 3, 2025 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced it has received seven awards in the 2025 Brandon Hall Group™ HCM Exce...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US6700021040
Novavax Inc
NVAX
LISTED
NASDAQ
Novavax to Participate in the Cantor Global Healthcare Conference
News Preview
GAITHERSBURG, Md., Sept. 3, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conference:
Cantor Global Healthcare Conference:
Fireside Chat
Date:
Thursday, September 4, 2025
Time:
10:20 a.m. ET
Location:
New York, NY
A webcast of the fireside chat will be available on th...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
Allergan Aesthetics Launches Campaign to Educate Consumers about Hyaluronic Acid (HA) Injectable Fillers
News Preview
First-of-its-kind report is available at www.naturallyyouwithHA.com Deep dive into category education and data on HA injectable fillers and the natural-looking results they can achieveIRVINE, Calif., Sept. 3, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, has launched the "Naturally You with Injectable Hyaluronic Acid Fillers" campa...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Newsfile
03.09.2025
ISIN: US29415V1098
Envoy Medical, Inc.
COCH
LISTED
NASDAQ
Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant
News Preview
No Serious Adverse Events or Unanticipated Device Effects Reported; Company Confirms Program Remains On TrackWhite Bear Lake, Minnesota--(Newsfile Corp. - September 3, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted technologies, today announced that the p...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
03.09.2025
ISIN: US00846U1016
Agilent Technologies Inc
A
LISTED
NYSE
Agilent to Showcase New Dako Omnis Family at European Congress of Pathology 2025
News Preview
Agilent Technologies Inc. (NYSE: A) today announced its participation as a premium sponsor at the upcoming European Congress of Pathology (ECP) 2025, taking place in Vienna, Austria, from September 6–10, 2025. Agilent will spotlight the European launch of its newly expanded Dako Omnis Family of instruments.
The Dako Omnis family, including the D...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
Astria Therapeutics to Present Initial Data from Phase 1a Trial of STAR-0310 at Upcoming European Academy of Dermatology & Venereology Congress 2025
News Preview
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present initial data from the Phase 1a trial of STAR-0310 at the European Academy of Dermatology & Venereology (EADV) Congress 2025, taking place September 17-20,...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US45257U1088
Immunome Inc
IMNM
LISTED
NASDAQ
Immunome to Present at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at the H.C. Wainwright 27th Annual Global Investment Conference on Tuesday, Sept. 9, 2025 at 1:00 p.m. Eastern Time.
Interested parties can access the live...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US90184D1000
Twist Bioscience Corp
TWST
LISTED
NASDAQ
Twist Bioscience to Present at Baird 2025 Global Healthcare Conference
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025 at 9:40 am Eastern Time in New York City. The company will also host one-on-one mee...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US1598641074
Charles River Laboratories International Inc
CRL
LISTED
NYSE
Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) and Akadeum Life Sciences, a leader in advanced cell separation technologies, announced today the integration of Akadeum’s GMP-grade Human T Cell Leukopak Isolation Kit into Charles River’s Cell Therapy Flex Program.
Charles River’s Cell Therapy Flex Platform originated as an off-the-she...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US75120L1008
Rallybio Corp
RLYB
LISTED
NASDAQ
Rallybio Receives $12.5 Million Equity Milestone Payment from Recursion for Advancement of REV102 Program
News Preview
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced that it received an equity milestone payment of $12.5 million from Recursion. The milestone payment was triggered by the initiation of additional prec...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLCLEI: 5493003YBCY4W1IMJU04NET ASSET VALUEThe estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 2 September 2025 was 362.57p (cum income). ...
Themefolio
Profiler
Peergroup
© Newsfile
03.09.2025
ISIN: US71880W5013
Phio Pharmaceuticals Corp.
PHIO
LISTED
NASDAQ
Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Clinical trial advances to anticipated final cohort for INSTASYL siRNA lead product candidate PH-7625th cohort patients now being treated in on-going clinical studyKing of Prussia, Pennsylvania--(Newsfile Corp. - September 3, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics usin...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
03.09.2025
ISIN: US68764Y2072
OS Therapies, Inc
OSTX
LISTED
XASE
OS Therapies to Participate in Upcoming Investor Conferences in September 2025
News Preview
New York, New York--(Newsfile Corp. - September 3, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced that it will participate in the upcoming investor conferences:Cantor Global Healthcare Conference 2025 being he...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US1140822099
Eterna Therapeutics Inc.
ERNA
LISTED
NASDAQ
Ernexa Therapeutics Announces Presentation At The H.C. Wainwright 27th Annual Global Investment Conference
News Preview
CAMBRIDGE, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced it will be featured as a presenting company at the H.C. Wainwright 27th Annual Global Investment Conference, being held Septembe...
Themefolio
Profiler
Peergroup
© Newsfile
03.09.2025
ISIN: CA68405H1001
Optimi Health Corp
OPTI
LISTED
CSE
Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant Depression
News Preview
Export of 1,000 natural psilocybin capsules for prescription use under Australia's Authorised Prescriber Scheme follows the Company's successful launch of MDMA sales in 2024Vancouver, British Columbia--(Newsfile Corp. - September 3, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian manufacture...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: CA71719L1067
Pharmala Biotech Holdings Inc.
MDMA
LISTED
CSE
PharmAla Incorporates Australian Entity for Clinical Research
News Preview
PharmAla incorporates a new entity in Australia to take advantage of tax incentives, and appoints Dr. Evan Lewis to its clinical advisory board....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US92829J2033
Virios Therapeutics Inc
DWTX
LISTED
NASDAQ
Dogwood Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
ATLANTA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biotechnology company developing new medicines to treat pain and fatigue-related disorders, today announces it will participate in the H.C. Wainwright 27th Annual Global Investment Conference. The conference is being held on...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US69404D1081
Pacific Biosciences of California Inc
PACB
LISTED
NASDAQ
PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow
News Preview
New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cancer New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cance...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US89422G1076
Travere Therapeutics Inc
TVTX
LISTED
NASDAQ
Travere Therapeutics Presents Abstracts at the 15th International Congress of Inborn Errors of Metabolism
News Preview
Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the Company shared two oral presentations in classical homocystinuria (HCU) at the International Congress of Inborn Errors of Metabolism, taking place September 2-6 in Kyoto, Japan.
New long-term data from Cohort 6 of the Phase 1/2 COMPOSE open-label extension (OLE) Study demonstrat...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US01438T1060
Aldeyra Therapeutics Inc
ALDX
LISTED
NASDAQ
Aldeyra Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 27th Ann...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US66987V1098
Novartis AG (ADR)
NVS
LISTED
NYSE
Argo Biopharma Announces Multi-Asset License and Option Agreements with Novartis for Novel Molecules for Cardiovascular Diseases
News Preview
Agreement to explore Argo's Phase 2 ANGPTL3 in a combination trial in dyslipidemia with an option to license second-generation molecules in the pipelineLicense to an additional Argo siRNA candidate currently in IND-enabling studiesArgo will receive an upfront payment of $160 million, an option for Profit & Loss split across multiple geographi...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US74017N1054
Precigen Inc
PGEN
LISTED
NASDAQ
Precigen Announces Up to $125 Million Non-Dilutive Financing
News Preview
$100 million funded at close fortifies balance sheet and supports robust US commercialization of PAPZIMEOS, as well as potential expansion into international markets and the pursuit of pediatric and other HPV-related indications
GERMANTOWN, Md., Sept. 2, 2025 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US86627T1088
Summit Therapeutics Inc
SMMT
LISTED
NASDAQ
Summit Therapeutics to Host Update Call at WCLC 2025 on September 8, 2025
News Preview
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) will host a call to discuss the ivonescimab data from our global Phase III clinical trial, HARMONi, presented as part of the Presidential Symposium at the International Association for the Study of Lung Cancer’s (IASLC) 2025 World Conference on Lung Cancer (WCLC 2025) in Ba...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US69012T2069
Outlook Therapeutics, Inc.
OTLK
LISTED
NASDAQ
Outlook Therapeutics to Present at the 2025 EURETINA Innovation Spotlight (EIS)
News Preview
ISELIN, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it will present at the EURETINA Innovation Spotlight being held as part of the 25th EURETINA Congress on Septe...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US5288723027
Lexicon Pharmaceuticals Inc
LXRX
LISTED
NASDAQ
Lexicon Pharmaceuticals Announces Presentation of Diabetic Peripheral Neuropathic Pain Patient Insights at PAINWeek 2025
News Preview
THE WOODLANDS, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced data from a study of patients describing the physical and psychological impact of diabetic peripheral neuropathic pain (DPNP), despite treatment with available over-the-counter and prescription pain relievers will be presented at...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US15119A2024
Celsus Therapeutics PLc
CLTX
LISTED
NASDAQ
Akari Therapeutics to Participate in the Virtual Investor Closing Bell Series
News Preview
Live moderated webcast on Thursday, September 4th at 4:00 PM ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US15117F3029
Cellectar Biosciences, Inc.
CLRB
LISTED
NASDAQ
Cellectar Biosciences to Present Data in Poster Presentation at the American Association for Cancer Research Special Conference on Advances in Pancreatic Cancer Research
News Preview
FLORHAM PARK, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the acceptance of an abstract for poster presentation at the American Association for Cancer Research (AAC...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US6294441000
NRx Pharmaceuticals, Inc.
NRXP
LISTED
NASDAQ
NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th
News Preview
WILMINGTON, Del., Sept. 03, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE," or the "Company"), an interventional psychiatry network wholly owned by NRx Pharmaceuticals, today announced that Jonathan Javitt...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US50127T1097
Kura Oncology Inc
KURA
LISTED
NASDAQ
Kura Oncology to Host Virtual Investor and Analyst Events on Farnesyl Transferase Inhibitor Program
News Preview
September 16 event to highlight preclinical data on the combination of FTI agents with multiple classes of targeted therapies...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US83006G1040
60 Degrees Pharmaceuticals, Inc.
SXTP
LISTED
NASDAQ
60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference
News Preview
60 Degrees Pharma (Nasdaq: SXTP) CEO Dr. Geoff Dow to present at HCW Conference Tuesday, Sept 9, 3:30 PM ET. Live webcast link available....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US19188J4094
Cocrystal Pharma Inc
COCP
LISTED
NASDAQ
Cocrystal Pharma to Participate at the H.C. Wainwright Global Investment Conference
News Preview
BOTHELL, Wash., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a company overview at the H.C. Wainwright 27th Annual Global Investment Conference on Tuesday, September 9, 2025 at 12:00 p.m. Eastern time....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US15713L1098
CervoMed Inc.
CRVO
LISTED
NASDAQ
CervoMed to Participate in Upcoming Investor Conferences
News Preview
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that Company management will participate in the following investor conferences during the month of September:...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US6024961012
MiMedx Group Inc
MDXG
LISTED
NASDAQ
MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall
News Preview
To Present Six Posters Featuring the Company’s Latest Product Innovations To Present Six Posters Featuring the Company’s Latest Product Innovations...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US1569441009
CG Oncology, Inc.
CGON
LISTED
NASDAQ
CG Oncology Completes Enrollment in PIVOT-006
News Preview
– Rapid enrollment underscores high unmet need in intermediate-risk non-muscle invasive bladder cancer (NMIBC) –– One of the largest randomized phase 3 studies in this patient population will encompass broadest range of patient types per AUA/SUO Guidelines –...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US29251M1062
Enanta Pharmaceuticals Inc
ENTA
LISTED
NASDAQ
Enanta Pharmaceuticals Announces the Passing of its Beloved and Respected Longtime Chief Financial and Administrative Officer Paul J. Mellett Jr.
News Preview
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) today announced the passing of its beloved and respected longtime Chief Financial and Administrative Officer Paul J. Mellett Jr.
“The entire Enanta team mourns the loss of Paul, our colleague and friend,” said Jay R. Luly, Ph.D., President and Chief Executive Officer of Enanta Pharmaceuticals. “Since jo...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US88322Q1085
TG Therapeutics Inc
TGTX
LISTED
NASDAQ
TG Therapeutics Announces Completion of Existing Share Repurchase Program and Authorization of New $100 Million Program
News Preview
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that it has completed its previously authorized $100 million share repurchase program, which was initially announced in August 2024. Under that program, the Company repurchased a total of approximately 3.5 million shares of its common stock at an ave...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US92243G1085
Vaxcyte Inc
PCVX
LISTED
NASDAQ
Vaxcyte Advances VAX-31 Infant Phase 2 Dose-Finding Study with First Participants Receiving VAX-31 Optimized Dose
News Preview
VAX-31 Optimized Dose, with Majority of Serotypes Dosed at 4.4mcg and Balance at 3.3mcg, is Designed to Elicit Even Stronger Immune Responses in Infant Population to Protect Against Invasive Pneumococcal Disease (IPD)...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: SG9999014716
WAVE Life Sciences Ltd
WVE
LISTED
NASDAQ
Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
News Preview
Achieved durable production of serum AAT protein at levels associated with a lower risk of AATD liver and lung diseases following repeat 200 mg doses of WVE-006 (11.9 µM total AAT, 7.2 µM M-AAT) ...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US6979471090
Palvella Therapeutics Inc
PVLA
LISTED
NASDAQ
Palvella Therapeutics Strengthens Leadership with Appointment of Accomplished Scientist and Biopharmaceutical Executive David W. Osborne, Ph.D. as Chief Innovation Officer
News Preview
Co-Founder and former Chief Technical Officer of Arcutis Biotherapeutics brings extensive topical product development experience, including track record of translating science into commercially available therapies...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US03770N1019
Apogee Therapeutics Inc
APGE
LISTED
NASDAQ
Apogee Therapeutics to Participate at the Stifel 2025 Virtual Immunology and Inflammation Forum
News Preview
SAN FRANCISCO and BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Stifel 2025 Virtual Immunology and Inflammation Forum on Tuesday, September 16, 2025, at 11:30 a.m. E.T....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US98419J2069
XOMA Royalty Corp
XOMA
LISTED
NASDAQ
XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference
News Preview
EMERYVILLE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today its Chief Executive Officer, Owen Hughes, and Chief Investment Officer, Brad Sitko, will present a company update at the H.C. Wainwright 27th Annual Global Investment Conference....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US09075A1088
Bioventus Inc
BVS
LISTED
NASDAQ
Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
DURHAM, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, Bioventus Senior Vice-President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Wednesday, September 10, 2025,...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Shock Top and Auntie Anne’s® Make It Official - Beer Kneads Pretzels
News Preview
Fan-favorite brands launch “Beer Kneads Pretzels” campaign with exclusive sweepstakes, promo-code discounts and limited-edition merchandise Fan-favorite brands launch “Beer Kneads Pretzels” campaign with exclusive sweepstakes, promo-code discounts and limited-edition merchandise...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US10806X1028
BridgeBio Pharma, Inc.
BBIO
LISTED
NASDAQ
BridgeBio to Host Autosomal Dominant Hypocalcemia Type 1 (ADH1) Investor Webinar on Wednesday, September 10th at 8:00 am ET
News Preview
PALO ALTO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced the Company will host an investor webinar on Wednesday, September 10, 2025 at 8:00 am ET with Rachel Gafni, M.D., Senior Research Physician...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US19243B1026
Cognition Therapeutics, Inc.
CGTX
LISTED
NASDAQ
Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer’s Disease Reaches 75% Enrollment Target
News Preview
PURCHASE, N.Y., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that the Phase 2 ‘START’ Study has reached the 75% enrollment mark. The START Study is enrolling approximately 540 individuals with...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US12529R1077
C4 Therapeutics Inc
CCCC
LISTED
NASDAQ
C4 Therapeutics to Present Data from the Phase 1 Trial of Cemsidomide in Multiple Myeloma at the International Myeloma Society (IMS) Annual Meeting
News Preview
C4T to Host Webcast on September 20, 2025 at 3 pm ET C4T to Host Webcast on September 20, 2025 at 3 pm ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: CA98420Q1081
XORTX Therapeutics Inc
XRTX
LISTED
TSX
XORTX Initiates IND Preparation for XORLO™ in Gout Program
News Preview
Engagement with Allucent supports NDA pathway and advancement of late-stage gout program Engagement with Allucent supports NDA pathway and advancement of late-stage gout program...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US58468P2065
MediciNova Inc
MNOV
LISTED
NASDAQ
MediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
LA JOLLA, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces that Yuichi Iwaki, MD., Ph.D., President and CEO, and David H. Crean, PhD, Chief Business Officer wil...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US5015751044
Kymera Therapeutics Inc
KYMR
LISTED
NASDAQ
Kymera Therapeutics Appoints Brian Adams as Chief Legal Officer and Corporate Secretary
News Preview
WATERTOWN, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the appointment of Brian Adams, JD, as Chief Legal Officer and Corporate Secretary. Mr. Adams is a hig...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US35168W1036
Fractyl Health Inc
GUTS
LISTED
NASDAQ
Fractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic Growth
News Preview
Appointments include Christopher Thompson, M.D. and Ian Sheffield as Independent Directors Appointments include Christopher Thompson, M.D. and Ian Sheffield as Independent Directors...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US89854M1018
TScan Therapeutics, Inc.
TCRX
LISTED
NASDAQ
TScan Therapeutics to Participate in Upcoming Investor Conferences
News Preview
WALTHAM, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced that the Company will participate in the following upcoming investor c...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US05153U1079
Aura Biosciences Inc
AURA
LISTED
NASDAQ
Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will present at the H.C. Wainwright 27th Annual Global Investment Co...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US09058V1035
BioCryst Pharmaceuticals Inc
BCRX
LISTED
NASDAQ
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted nine newly-hired employees stock options to purchase an aggregate of 36,700 shares, and restricted stock units (RSUs) covering an aggregate of 71,40...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Breckenridge Distillery Expands California Distribution with Winebow
News Preview
BRECKENRIDGE, Colo., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), has announced a strategic change in its California distribution approach, appointing Winebow, a respected national partner, to manage distribution responsibili...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.09.2025
ISIN: US01989F2083
Allstar Health Brands, Inc.
ALST
LISTED
OTC
Allstar Global Brands Partners with MAS + DRINK AT Milton Soccer for USA Cup Qualifier in Late August
News Preview
Empowering Young Athletes with "Be Your Best" Technology to Enhance Player Development MIAMI, FL / ACCESS Newswire / September 3, 2025 / Allstar Global Brands is proud to announce an exciting partnership with Milton Soccer to sponsor and support their involvement in the USA Cup Qualifier scheduled for late August. This collaboration marks...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US6551872012
Aclarion, Inc.
ACON
LISTED
NASDAQ
Aclarion Appoints Greg Gould as Chief Financial Officer
News Preview
Aclarion Appoints Greg Gould as Chief Financial Officer...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Sept. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nutex Health Inc. ("Nutex" or "the Company") (NASDAQ: NUTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.09.2025
ISIN: US36257K2087
Marijuana Inc.
MAJI
LISTED
OTC
Exousia Pro Creates New Subdivisions
News Preview
Exousia Pro aims to develop three new subdivisions and launch new products during the 4th quarter.The market for our new products is currently valued at $8.7 billion, projected to grow to $18.5 billion over the next decade. ORLANDO, FLORIDA / ACCESS Newswire / September 3, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotech company ut...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.09.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies Inc. (OTC PINK:MDCE) Launches AI Wound Monitoring Tool for $20+ Billion Chronic Care Market
News Preview
MESA, ARIZONA / ACCESS Newswire / September 3, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced its AI-powered Wound Monitoring System, designed to provide real-time wound care diagnostics using only smartphone imagery.The platform applies sequential imaging algorithms, automated edge detection, and infection risk modeling to t...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.09.2025
ISIN: GB00BYX3WZ24
Hemogenyx Pharmaceuticals plc
HEMO
LISTED
LSE
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
News Preview
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN. LON...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
